{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:11:17Z","timestamp":1781766677018,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 DK119800"],"award-info":[{"award-number":["R21 DK119800"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001067","name":"Juvenile Diabetes Research Foundation Australia","doi-asserted-by":"publisher","award":["1-SRA-2020-900"],"award-info":[{"award-number":["1-SRA-2020-900"]}],"id":[{"id":"10.13039\/501100001067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["3-PDF-2019-752-A-N"],"award-info":[{"award-number":["3-PDF-2019-752-A-N"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00125-021-05573-6","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T09:04:31Z","timestamp":1634115871000},"page":"88-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6170-1156","authenticated-orcid":false,"given":"Jamie L.","family":"Felton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3785-9834","authenticated-orcid":false,"given":"David","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Lohano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3702-2444","authenticated-orcid":false,"given":"Farah","family":"Meah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-3529","authenticated-orcid":false,"given":"John M.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7204-8367","authenticated-orcid":false,"given":"Jay","family":"Sosenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-8663","authenticated-orcid":false,"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Type 1 Diabetes TrialNet Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"23","key":"5573_CR1","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473\u20132479. https:\/\/doi.org\/10.1001\/jama.2013.6285","journal-title":"JAMA"},{"issue":"3","key":"5573_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s00125-019-05047-w","volume":"63","author":"LM Jacobsen","year":"2020","unstructured":"Jacobsen LM, Bocchino L, Evans-Molina C et al (2020) The risk of progression to type 1 diabetes is highly variable in individuals with mulitple autoantibodies following screening. Diabetologia 63(3):588\u2013596. https:\/\/doi.org\/10.1007\/s00125-019-05047-w","journal-title":"Diabetologia"},{"issue":"10","key":"5573_CR3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38(10):1964\u20131974. https:\/\/doi.org\/10.2337\/dc15-1419","journal-title":"Diabetes Care"},{"issue":"7","key":"5573_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold KC, Bundy BN, Long SA et al (2019) An anti-CD3 antibody, Teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 381(7):603\u2013613. https:\/\/doi.org\/10.1056\/NEJMoa1902226","journal-title":"N Engl J Med"},{"issue":"22","key":"5573_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa012350","volume":"346","author":"JS Skyler","year":"2002","unstructured":"Skyler JS, Brown D, Chase HP et al (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346(22):1685\u20131691. https:\/\/doi.org\/10.1056\/NEJMoa012350","journal-title":"N Engl J Med"},{"key":"5573_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jaut.2016.03.008","volume":"71","author":"MR Ehlers","year":"2016","unstructured":"Ehlers MR (2016) Strategies for clinical trials in type 1 diabetes. J Autoimmun 71:88\u201396. https:\/\/doi.org\/10.1016\/j.jaut.2016.03.008","journal-title":"J Autoimmun"},{"issue":"7","key":"5573_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JRPR, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"issue":"12","key":"5573_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21(12):2191\u20132192. https:\/\/doi.org\/10.2337\/diacare.21.12.2191","journal-title":"Diabetes Care"},{"issue":"5","key":"5573_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2337\/diacare.22.5.818","volume":"22","author":"M Emoto","year":"1999","unstructured":"Emoto M, Nishizawa Y, Maekawa K et al (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22(5):818\u2013822. https:\/\/doi.org\/10.2337\/diacare.22.5.818","journal-title":"Diabetes Care"},{"issue":"9","key":"5573_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/diabetes.48.9.1779","volume":"48","author":"MP Hermans","year":"1999","unstructured":"Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of tests of \u03b2-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48(9):1779\u20131786. https:\/\/doi.org\/10.2337\/diabetes.48.9.1779","journal-title":"Diabetes"},{"key":"5573_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1447.054","volume":"1150","author":"JS Skyler","year":"2008","unstructured":"Skyler JS, Greenbaum CJ, Lachin JM et al (2008) Type 1 diabetes TrialNet - an international collaborative clinical trials network. Ann N Y Acad Sci 1150:14\u201324. https:\/\/doi.org\/10.1196\/annals.1447.054","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"5573_CR12","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2337\/dc11-0560","volume":"34","author":"K Vehik","year":"2011","unstructured":"Vehik K, Beam CA, Mahon JL et al (2011) Development of autoantibodies in the TrialNet natural history study. Diabetes Care 34(9):1897\u20131901. https:\/\/doi.org\/10.2337\/dc11-0560","journal-title":"Diabetes Care"},{"issue":"2","key":"5573_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1399-5448.2008.00464.x","volume":"10","author":"JL Mahon","year":"2009","unstructured":"Mahon JL, Sosenko JM, Rafkin-Mervis L et al (2009) The TrialNet natural history study of the development of type 1 diabetes: objectives, design, and initial results. Pediatr Diabetes 10(2):97\u2013104. https:\/\/doi.org\/10.1111\/j.1399-5448.2008.00464.x","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"5573_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2337\/dc11-2081","volume":"35","author":"L Yu","year":"2012","unstructured":"Yu L, Boulware DC, Beam CA et al (2012) Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 35(6):1213\u20131218. https:\/\/doi.org\/10.2337\/dc11-2081","journal-title":"Diabetes Care"},{"issue":"10","key":"5573_CR15","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/dc07-2451","volume":"31","author":"CJ Greenbaum","year":"2008","unstructured":"Greenbaum CJ, Thomas MP, Mcgee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of \u03b2-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31(10):1966\u20131971. https:\/\/doi.org\/10.2337\/dc07-2451","journal-title":"Diabetes Care"},{"issue":"2","key":"5573_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1399-5448.2010.00662.x","volume":"12","author":"JM Sosenko","year":"2011","unstructured":"Sosenko JM, Mahon J, Rafkin L et al (2011) A comparison of the baseline metabolic profiles between diabetes prevention trial-type 1 and TrialNet natural history study participants. Pediatr Diabetes 12(2):85\u201390. https:\/\/doi.org\/10.1111\/j.1399-5448.2010.00662.x","journal-title":"Pediatr Diabetes"},{"issue":"23\u201324","key":"5573_CR17","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.cca.2011.07.019","volume":"412","author":"JL Mahon","year":"2011","unstructured":"Mahon JL, Beam CA, Marcovina SM et al (2011) Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies. Clin Chim Acta 412(23\u201324):2128\u20132131. https:\/\/doi.org\/10.1016\/j.cca.2011.07.019","journal-title":"Clin Chim Acta"},{"issue":"Supplement 1","key":"5573_CR18","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association (2014) Standards of medical Care in Diabetes - 2014. Diabetes Care 37(Supplement 1):S14\u2013S80. https:\/\/doi.org\/10.2337\/dc14-S014","journal-title":"Diabetes Care"},{"issue":"8","key":"5573_CR19","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/clinchem\/41.8.1248","volume":"41","author":"EK Shultz","year":"1995","unstructured":"Shultz EK (1995) Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example. Clin Chem 41(8):1248\u20131255. https:\/\/doi.org\/10.1093\/clinchem\/41.8.1248","journal-title":"Clin Chem"},{"issue":"1","key":"5573_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","journal-title":"Cancer"},{"issue":"1","key":"5573_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","volume":"43","author":"M Battaglia","year":"2020","unstructured":"Battaglia M, Ahmed S, Anderson MS et al (2020) Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care 43(1):5\u201312. https:\/\/doi.org\/10.2337\/dc19-0880","journal-title":"Diabetes Care"},{"issue":"6","key":"5573_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2337\/db11-1660","volume":"61","author":"JM Sosenko","year":"2012","unstructured":"Sosenko JM, Skyler JS, Herold KC, Palmer JP (2012) The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the diabetes prevention trial-type 1. Diabetes 61(6):1331\u20131337. https:\/\/doi.org\/10.2337\/db11-1660","journal-title":"Diabetes"},{"issue":"15","key":"5573_CR23","doi-asserted-by":"publisher","first-page":"e120877","DOI":"10.1172\/jci.insight.120877","volume":"3","author":"C Evans-Molina","year":"2018","unstructured":"Evans-Molina C, Sims EK, DiMeglio LA et al (2018) \u03b2 cell dysfunction exists more than 5 years before type 1 diabetes diagnosis. JCI Insight 3(15):e120877. https:\/\/doi.org\/10.1172\/jci.insight.120877","journal-title":"JCI Insight"},{"issue":"9","key":"5573_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2337\/dc08-2140","volume":"32","author":"JM Sosenko","year":"2009","unstructured":"Sosenko JM, Palmer JP, Rafkin-Mervis L et al (2009) Incident dysglycemia and progression to type 1 diabetes among participants in the diabetes prevention trial-type 1. Diabetes Care 32(9):1603\u20131607. https:\/\/doi.org\/10.2337\/dc08-2140","journal-title":"Diabetes Care"},{"issue":"4","key":"5573_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s00125-020-05365-4","volume":"64","author":"MJ Redondo","year":"2021","unstructured":"Redondo MJ, Nathan BM, Jacobsen LM et al (2021) Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia 64(4):836\u2013844. https:\/\/doi.org\/10.1007\/s00125-020-05365-4","journal-title":"Diabetologia"},{"issue":"2","key":"5573_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2337\/dc14-1813","volume":"38","author":"JM Sosenko","year":"2015","unstructured":"Sosenko JM, Skyler JS, Dimeglio LA et al (2015) A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history. Diabetes Care 38(2):271\u2013276. https:\/\/doi.org\/10.2337\/dc14-1813","journal-title":"Diabetes Care"},{"issue":"11","key":"5573_CR27","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2337\/dc17-0916","volume":"40","author":"BM Nathan","year":"2017","unstructured":"Nathan BM, Boulware D, Geyer S et al (2017) Dysglycemia and Index60 as Prediagnostic end points for type 1 diabetes prevention trials. Diabetes Care 40(11):1494\u20131499. https:\/\/doi.org\/10.2337\/dc17-0916","journal-title":"Diabetes Care"},{"issue":"6","key":"5573_CR28","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27(6):1487\u20131495. https:\/\/doi.org\/10.2337\/diacare.27.6.1487","journal-title":"Diabetes Care"},{"key":"5573_CR29","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/0168-8227(95)01105-M","volume":"28","author":"RC Turner","year":"1995","unstructured":"Turner RC, Holman RR (1995) Lessons from UK prospective diabetes study. Diabetes Res Clin Pract 28:S151\u2013S157. https:\/\/doi.org\/10.1016\/0168-8227(95)01105-M","journal-title":"Diabetes Res Clin Pract"},{"key":"5573_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M","volume":"15","author":"J Levy","year":"1998","unstructured":"Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR (1998) Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast diet study. Diabet Med 15:290\u2013296. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M","journal-title":"Diabet Med"},{"issue":"4","key":"5573_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/ajt.14620","volume":"18","author":"JE Go\u0142\u0119biewska","year":"2018","unstructured":"Go\u0142\u0119biewska JE, Solomina J, Thomas C et al (2018) Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation. Am J Transplant 18(4):990\u2013997. https:\/\/doi.org\/10.1111\/ajt.14620","journal-title":"Am J Transplant"},{"issue":"9","key":"5573_CR32","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.2337\/dc06-2389","volume":"30","author":"P Xu","year":"2007","unstructured":"Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP (2007) Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30(9):2314\u20132320. https:\/\/doi.org\/10.2337\/dc06-2389","journal-title":"Diabetes Care"},{"issue":"10","key":"5573_CR33","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00125-004-1507-3","volume":"47","author":"S Fourlanos","year":"2004","unstructured":"Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47(10):1661\u20131667. https:\/\/doi.org\/10.1007\/s00125-004-1507-3","journal-title":"Diabetologia"},{"issue":"3","key":"5573_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5603\/EP.2014.0024","volume":"65","author":"K Siewko","year":"2014","unstructured":"Siewko K, Pop\u0142awska-Kita A, Telejko B et al (2014) Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients. Endokrynol Pol 65(3):176\u2013180. https:\/\/doi.org\/10.5603\/EP.2014.0024","journal-title":"Endokrynol Pol"},{"key":"5573_CR35","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00125-002-0949-8","volume":"45","author":"FK Gorus","year":"2002","unstructured":"Gorus FK, Decochez K, De Leeuw IH et al (2002) IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 45:1658\u20131666. https:\/\/doi.org\/10.1007\/s00125-002-0949-8","journal-title":"Diabetologia"},{"issue":"3","key":"5573_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/pedi.12812","volume":"20","author":"LM Jacobsen","year":"2019","unstructured":"Jacobsen LM, Larsson HE, Tamura RN et al (2019) Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children. Pediatr Diabetes 20(3):263\u2013270. https:\/\/doi.org\/10.1111\/pedi.12812","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"5573_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00125-018-4774-0","volume":"62","author":"P Narendran","year":"2019","unstructured":"Narendran P (2019) Screening for type 1 diabetes: are we nearly there yet? Diabetologia 62(1):24\u201327. https:\/\/doi.org\/10.1007\/s00125-018-4774-0","journal-title":"Diabetologia"},{"issue":"4","key":"5573_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jama.2019.21565","volume":"323","author":"AG Ziegler","year":"2020","unstructured":"Ziegler AG, Kick K, Bonifacio E et al (2020) Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA 323(4):339\u2013351. https:\/\/doi.org\/10.1001\/jama.2019.21565","journal-title":"JAMA"},{"issue":"3","key":"5573_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-8227(98)00086-2","volume":"41","author":"A Costa","year":"1998","unstructured":"Costa A, Rios M, Casamitjana R, Gomis R, Conget I (1998) High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community. Diabetes Res Clin Pract 41(3):191\u2013196. https:\/\/doi.org\/10.1016\/S0168-8227(98)00086-2","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05573-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:10:31Z","timestamp":1665533431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05573-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5573"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05573-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}